Search - tctmd.com

Displaying 1 - 20 of 82

Sort: Relevancy | Date

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

Advertisement

Heart Disease Remains Number One Killer of Americans

January 2026 Dispatch for the CV Team

JACC Debuts Data Digest on CV Health in the United States

December 2025 Dispatch for the CV Team

Year in Review: Women’s Heart Health in the Spotlight

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

CVD Hospitalization in Older Adults Higher in US Than in Denmark

January 2025 Dispatch for the CV Team

November 2024 Dispatch for the CV Team

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

October 2023 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content